Fidelity Investments’s Vor Biopharma VOR Stock Holding History

Fidelity Investments’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.5M	Sell	1,539,670 -986,500	-39%	-$13.9M	﹤0.01%	1659
2025 Q4	$33M	Buy	2,526,170 +2,289,662	+968%	+$42.6M	﹤0.01%	1593
2025 Q3	$11.5M	Buy	236,508 +131,874	+126%	+$5.3M	﹤0.01%	1947
2025 Q2	$3.39M	Sell	104,634 -216,491	-67%	-$1.91M	﹤0.01%	2302
2025 Q1	$4.61M	Buy	321,125 +143	+0%	+$3.43K	﹤0.01%	2179
2024 Q4	$7.13M	Sell	320,982 -32,574	-9%	-$540K	﹤0.01%	2043
2024 Q3	$4.95M	Sell	353,556 -234	-0.1%	-$4.27K	﹤0.01%	2130
2024 Q2	$7.08M	Sell	353,790 -26,632	-7%	-$861K	﹤0.01%	1973
2024 Q1	$18M	Sell	380,422 -525	-0.1%	-$23.1K	﹤0.01%	1696
2023 Q4	$17.1M	Sell	380,947 -1,612	-0.4%	-$66.5K	﹤0.01%	1679
2023 Q3	$16.2M	Sell	382,559 -1,850	-0.5%	-$100K	﹤0.01%	1664
2023 Q2	$23.8M	Sell	384,409 -6,243	-2%	-$570K	﹤0.01%	1576
2023 Q1	$42M	Sell	390,652 -7,874	-2%	-$873K	﹤0.01%	1325
2022 Q4	$53M	Buy	398,526 +239,464	+151%	+$23.7M	0.01%	1229
2022 Q3	$12.7M	Sell	159,062 -221	-0.1%	-$21.7K	﹤0.01%	1802
2022 Q2	$15.8M	Buy	159,283 +5	+0%	+$512	﹤0.01%	1751
2022 Q1	$19.2M	Buy	159,278 +205	+0.1%	+$34.9K	﹤0.01%	1799
2021 Q4	$37M	Sell	159,073 -1,197	-0.7%	-$345K	﹤0.01%	1551
2021 Q3	$50.3M	Sell	160,270 -17,790	-10%	-$5.29M	﹤0.01%	1408
2021 Q2	$63.9M	Sell	178,060 -5,792	-3%	-$2.86M	0.01%	1325
2021 Q1	$147M	Buy	+183,852	New	+$156M	0.01%	920

Other funds holding VOR

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Fidelity Investments's VOR Position: Q1 2026 in Review

Fidelity Investments reduced its Vor Biopharma (VOR) stake by 39% in Q1 2026, selling an estimated $13.9M and leaving 1,539,670 shares worth $27.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Fidelity Investments first reported a position in VOR in Q1 2021 and has held it in 21 quarters since. The position peaked at $147M in Q1 2021. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

Fidelity Investments held 1,539,670 shares of Vor Biopharma worth $27.5M as of Q1 2026.
Fidelity Investments sold 986,500 Vor Biopharma shares in Q1 2026, an estimated $13.9M.
Vor Biopharma made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1659 holding.
Fidelity Investments first reported a position in Vor Biopharma in Q1 2021 and has held it in 21 quarters since.
Fidelity Investments's Vor Biopharma position peaked at $147M in Q1 2021.
80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.